基于 1 个已确定 T+90 收益的买入信号。收益基准:公布次日的收盘价。
Discover the full record of transactions filed by Daniels Ronald J, 董事. Officer active across 1 company, notably BridgeBio Pharma, Inc.. Aggregated, 4 reports have been published. Split: 1 buy · 0 sell. Total volume traded: €132k. Activity tracked since 28 December 2021. The latest transaction was filed on 6 November 2025 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Ronald J. Daniels is a Board Member at BridgeBio Pharma, Inc. He participates in the governance of the company and strategic decision-making. His experience in the pharmaceutical sector helps guide BridgeBio's initiatives.